Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Abbisko Teams Up With Lilly In Latest U.S.-China Pharma Collaboration
David Ricks, chief executive officer of Eli Lilly & Co., speaks during the China Development Forum in Beijing in March this year. Photographer: Qilai Shen/Bloomberg © 2026 Bloomberg Finance LP In the latest China pharmaceutical industry…
Washington and Pharma Are Helping China Win | Opinion
I don't often agree with Health and Human Services Secretary Robert F. Kennedy Jr., but he was right when he told Congress that China is 'eating our lunch' when it comes to developing new treatments and cures. The question facing the United States…
/afaqs/media/media_files/2026/06/24/honasa_fluence-2026-06-24-15-45-54.jpg)
Honasa Consumer enters nutraceuticals with majority stake in Fluence Pharma
Honasa Consumer, the parent company of brands such as Mamaearth, has entered the nutraceuticals category with the acquisition of a 58% stake in Fluence Pharma, a science-led supplements company known for its patented Cyclical Nutrition Therapy…
Dennis Bastas' pharma chief abruptly exits after less than six months
The executive that billionaire Dennis Bastas appointed to run his healthcare and beauty empire has abruptly departed after less than six months in the role in the latest management shake-up within DBG Health. Matt Zeller, who reported directly to…
Shifting Frontiers: How Clinical Milestones and Corporate Realities Are Shaping the 2026 Pharma Landscape
As the pharmaceutical sector navigates the midpoint of 2026, capital allocation strategies are highlighting a fascinating divergence between broad-scale oncology bets and highly targeted micro-caps solving specific cellular riddles. While the war…
India pharma sector shifts focus to biosimilars, biologics and high-value growth
The pharmaceutical sector is undergoing a strategic shift from volume-driven expansion to high-value global competitiveness, with increasing emphasis on quality, innovation and trust. Backed by $30 billion in annual exports and the highest number…
Honasa Consumer to acquire 58% stake in Fluence Pharma
Honasa Consumer Ltd, on Tuesday said it will acquire 58 per cent stake in Fluence Pharma, which is a science-backed nutraceuticals company. This marks the beauty and personal care company's entry in the rapidly growing nutraceuticals space In a BSE…
Stronger translational research, need of the hour for Indian Pharma: Dr Reddy's Chairman Satish Reddy
Indian pharma needs a step change from incremental progress to innovation at scale marked by stronger translational research pathways, K Satish Reddy, Chairman, Dr Reddy's Laboratories, said. In a white paper on translational research, Reddy said…
Honasa shares slip 3% after it announces acquisition of nutraceuticals maker Fluence Pharma
Shares of Honasa Consumer Ltd fell 3.07 per cent to ₹407 on Wednesday on the NSE, a day after the Mamaearth parent announced the acquisition of a majority 58 per cent stake in science-backed nutraceuticals company Fluence Pharma Private Ltd.
With Weight Loss Drugs, There's Evidently No Frontier
Photo Illustration of the new Wegovy semaglutide tablets with injectable prescription weight loss medicines, Ozempic, Victoza and Wegovy. Its a prescription medicine used with a reduced calorie diet and physical activity. (Photo by: Michael…
US decries the 'free ride' countries with public health systems are getting by negotiating deals for prescription drugs
The Trump administration has launched an investigation into Germany's pharmaceutical pricing, claiming that “persistent underpayment” for drugs is forcing Americans to subsidize research and development (R & D) globally. And it's…
Johnson & Johnson: Not Every Dollar Needs To Chase The AI Boom (Upgrade) (NYSE:JNJ)
Johnson & Johnson (JNJ) is upgraded from Hold to Buy, driven by consistent performance, stable revenue growth, and defensive characteristics. JNJ trades at a 20x forward P/E, a justified 12% premium to peers, supported by above-industry margins and…
China detains two Japanese nationals suspected of smuggling banned goods
China has detained two Japanese nationals suspected of smuggling banned goods, Tokyo said on Wednesday after media reported that an employee of a major Japanese electronics firm was among those arrested in a case involving rare earth-related…
Galectin De-Risks Belapectin Path With FDA Alignment - Sets Stage For Phase 3 Upside
Galectin Therapeutics remains a buy as recent FDA alignment de-risks belapectin's Phase 3 path and clarifies regulatory endpoints. The FDA's endorsement of a single, well-controlled Phase 3 trial with a composite clinical outcome endpoint reduces…
Danaher Is Down 22% This Year. Is the Masimo Acquisition the Entry Point Investors Have Been Waiting for?
Danaher (DHR +5.01%) focuses on life sciences, diagnostics, and industrial solutions for healthcare and sells specialized equipment, software, consumables, and reagents used by pharmaceutical companies, scientific research labs, and hospitals. The…
Receive a Daily briefing on Pharma Industry News
Get Started